Skip to main content
. Author manuscript; available in PMC: 2016 Mar 30.
Published in final edited form as: Brain Res. 2015 Jan 9;1602:119–126. doi: 10.1016/j.brainres.2015.01.004

Table 3.

Experimental Group Information

HiS MOR LoS MOR HiS SAL LoS SAL
Mean (±SEM) saccharin scorea 13.2 ± 3.0 11.0 ± 2.3 14.7 ± 2.2 8.7 ± 1.7
Mean (±SEM) ICSS threshold baseline(μA) for phase 2 (morphine dependence induction) 152.6 ± 27.1 133.3 ± 8.9 136.6 ± 29.4 136.46 ± 10.0
Mean (±SEM) response latency (s) baseline for phase 2 (morphine dependence induction) 2.7 ± 0.3* 3.0 ± 0.1 2.6 ± 0.1* 3.1 ± 0.1
Mean (±SEM) ICSS threshold baseline (μA) for phase 4 (precipitated withdrawal) 152.0 ± 25.5 136.4 ± 7.6 132.1 ± 22.8 136.1 ± 8.1
Mean (±SEM) response latency (s) baseline for phase 4 (precipitated withdrawal) 2.7 ± 0.3 2.7 ± 0.2 2.4 ± 0.2 3.1 ± 0.1
a

Saccharin phenotype score = {[24-h saccharin intake (mL)–average water intake (mL)/weight (g)]×100}

*

Main effect of phenotype (HiS<LoS; p < .05)

HiS = high saccharin rats; LoS = low saccharin rats; MOR = morphine; SAL = saline